Product Information
ROFLUMILAST 500 MCG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.3204 per EA under NDC 31722062330. Its NADAC has been published 184 times since Dec 21, 2022.
Strength
500 ug/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722062330
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROFLUMILASTApproval Type
Generic (ANDA)
FDA Application
ANDA208213On Market Since
10/15/2022
Pharmacological Classes
Price Statistics
The NADAC for ROFLUMILAST 500 MCG TABLET has been published 184 times since Dec 21, 2022, and over the history we have for it it has declined 86.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3204 per EA |
|---|---|
| All-time high | $2.3102 (Jan 11, 2023) |
| All-time low | $0.2563 (Nov 20, 2024) |
| 52-week high | $0.3654 |
| 52-week low | $0.3118 |
| Median price | $0.3584 |
| Average price | $0.4666 |
| Largest weekly change | -70.0% (Jan 18, 2023) |
| Weeks tracked | 184 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROFLUMILAST 500 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROFLUMILAST 500 MCG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.3204 per EA (NDC 31722062330), effective Jun 24, 2026.
How has the price of ROFLUMILAST 500 MCG TABLET changed over time?
Over the history we have for it, the NADAC for ROFLUMILAST 500 MCG TABLET has declined 86.1%. It has been tracked across 184 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for ROFLUMILAST 500 MCG TABLET?
Since Dec 21, 2022, the NADAC for ROFLUMILAST 500 MCG TABLET has ranged from a low of $0.2563 (Nov 20, 2024) to a high of $2.3102 (Jan 11, 2023), with a median of $0.3584 per EA.
Are there cheaper alternatives to ROFLUMILAST 500 MCG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as ROFLUMILAST 500 MCG TABLET, but none are currently priced below it.
Who manufactures ROFLUMILAST 500 MCG TABLET?
ROFLUMILAST 500 MCG TABLET (NDC 31722062330) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification